The market on Tuesday ended with smart gains as the Sensex gained 440.35 points or 1.6 percent at 28343.01, and the Nifty closed up 136.90 points or 1.6 percent at 8744.35.
Shares such as Bajaj Auto, Asian Paints, Maruti, GAIL and HDFC Bank were gainers were gainers while Bharti was down three percent.
Crompton Greaves, the electrical energy solutions provider, turned profitable in the quarter ended June 2016 on account of strong revenue and operational growth. Profit stood at Rs. 40 crore for the quarter against loss of Rs. 63.7 crore in year-ago period.
"The loss from discontinued operations after tax stood at Rs. 49.57 crore in Q1 against profit of Rs. 1.47 crore in corresponding period of last fiscal and loss of Rs. 223.8 crore in preceding period," the company said.
Drug firm Cipla today said its US arm InvaGen Pharmaceuticals Inc has received final approval from the American health regulator to market generic Bupropion Hydrochloride extended release tablets used for treatment of major depressive disorder.
"InvaGen Pharmaceuticals Inc has received final approval for its abbreviated new drug application (ANDA) for Bupropion Hydrochloride extended release tablets (XL), 150 mg and 300 mg, from the United States Food and Drug Administration," Cipla said in a statement.
The product is available for shipping immediately, it added.
The company's tablets are generic versions of Valeant's Wellbutrin XL tablets in the same strengths, Cipla said.
"The tablets are indicated for the treatment of major depressive disorder (MDD) and prevention of seasonal affective disorder (SAD)," it added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
